TELESM-edu.Nursing: Efficacy of a Personalised Nursing Intervention for the Management of People With Multiple Sclerosis

Not yet recruitingNot a drug-phase studyRelapsing and progressiveNCT07640698

What it found

Still running

No result yet.

What was tested

Treatment tested

  • TELESM-edu.nursing

Compared with

  • Standard

What it measured

Main measures

  • Change in Navigational Health Literacy (Ability to Navigate Health Systems and Services) Assessed by the HLS19-NAV Instrument From Baseline to 6-Month Follow-up

    Assessed at baseline, 3 months, and at the 6-month final follow-up.

  • Change in Health Literacy Level Assessed by the Single-Item Literacy Screener (SILS) From Baseline to 6-Month Follow-up

    Assessed at baseline, 3 months, and at the 6-month final follow-up.

  • Change in Patient Satisfaction With Current Therapy Assessed by a Single-Item Satisfaction Measure From Baseline to 6-Month Follow-up

    Assessed at baseline and at the 6-month final follow-up.

    Quality of life (reported by participants)Safety
  • Change in Beliefs About the Necessity of Prescribed Medicines Assessed by the Beliefs about Medicines Questionnaire-Specific (BMQ-Specific) Necessity Subscale From Baseline to 6-Month Follow-up

    Assessed at baseline and at the 6-month final follow-up.

  • Change in Concerns About Prescribed Medicines Assessed by the Beliefs about Medicines Questionnaire-Specific (BMQ-Specific) Concerns Subscale From Baseline to 6-Month Follow-up

    Assessed at baseline and at the 6-month final follow-up.

  • Change in Trust in Nurses Assessed by the Trust in Nurses Scale (TNS) From Baseline to 6-Month Follow-up

    Assessed at baseline, 3 months, and at the 6-month final follow-up.

  • Satisfaction of Patients' Informational Needs at 6-Month Follow-up

    Assessed at the 6-month final follow-up.

    Quality of life (reported by participants)
  • Change in Disability Level Assessed by the Expanded Disability Status Scale (EDSS) From Baseline to 6-Month Follow-up

    Assessed at baseline and at the 6-month final follow-up.

    Disability progression

Other measures (6)

  • Feasibility of the TELESM-edu.nursing Programme Assessed by Participant Retention and Adherence Rates Over the 6-Month Study Period

    Assessed at 3 months and at the 6-month final follow-up.

    Quality of life (reported by participants)Feasibility
  • Acceptability of the TELESM-edu.nursing Intervention Assessed by a TFA-Based Questionnaire at 6-Month Follow-up

    Assessed at the 6-month final follow-up.

    Feasibility
  • Usability of the TELESM-edu.nursing Intervention Assessed by a Single-Item Measure at 6-Month Follow-up

    Assessed at the 6-month final follow-up.

  • Satisfaction With the TELESM-edu.nursing Intervention Assessed by a Single-Item Measure at 6-Month Follow-up

    Assessed at the 6-month final follow-up.

    Quality of life (reported by participants)
  • Staff Satisfaction With the TELESM-edu.nursing Intervention Assessed Through Semi-Structured Interviews at 6-Month Follow-up

    Assessed at the 6-month final follow-up.

    Quality of life (reported by participants)
  • Staff-Perceived Usability of the TELESM-edu.nursing Intervention Assessed Through Semi-Structured Interviews at 6-Month Follow-up

    Assessed at the 6-month final follow-up.

Who could take part

Relapsing and progressive · 18 and over

Show the full criteria

Inclusion criteria

* Patients of both sexes (male and female) * Age 18 years or older * Confirmed diagnosis of relapsing-remitting multiple sclerosis (RRMS), primary progressive multiple sclerosis (PPMS), or secondary progressive multiple sclerosis (SPMS) * Currently receiving pharmacological treatment for multiple sclerosis * Expanded Disability Status Scale (EDSS) score of 7.5 or lower * Ability to read and understand Italian * Ability to provide written informed consent * Access to a suitable device (smartphone, tablet, or computer with a webcam) * Access to a home internet connection

Exclusion criteria

* Age younger than 18 years * Expanded Disability Status Scale (EDSS) score higher than 7.5 * Presence of psychiatric disorders that may interfere with participation in the study * Presence of cognitive impairment that may interfere with participation in the study

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

The primary aim of this study is to evaluate the impact of the telenursing intervention "TELESM-edu.nursing" on people with Multiple Sclerosis (pwMS), specifically focusing on their navigational capacity within the healthcare system (Navigation Health Literacy) and their perceived level of Health Literacy. The study will also assess the effectiveness of the intervention in improving patient satisfaction with current therapy, patients' beliefs and attitudes towards the prescribed therapeutic regimen, satisfaction of informational needs, trust in nurses, and degree of disability. The secondary objective is to evaluate the feasibility and sustainability of a personalised telenursing programme for pwMS. Feasibility will be assessed based on: (I) the ability to recruit and retain participants, measured through adherence rates and dropout rates in the intervention group; (II) participants' acceptability, usability, and satisfaction with the intervention; and (III) healthcare staff satisfaction and perceived usability of the intervention. The main research questions addressed in this study are: Does the "TELESM-edu.nursing" intervention improve patients' Navigation Health Literacy and overall Health Literacy levels? Does the intervention improve patient satisfaction with therapy and fulfilment of informational needs? Does the intervention positively influence patients' beliefs and attitudes towards their treatment? Does the intervention increase trust in nurses? What is the impact of the intervention on patients' level of disability? Is the telenursing programme feasible, acceptable, and sustainable for both patients and healthcare professionals? Both study groups will receive the standard in-person informational and educational programme, as well as routine follow-up visits according to the established care pathway. Participants assigned to the intervention group will additionally receive a personalised educational programme lasting six months. This programme will be delivered monthly by a nurse through educational video pills and nurse-led teleconsultations. Participants will be required to watch the video pills and take part in teleconsultations.

Loading reviews and guidelines…

History

    1. Started

      Jul 2026

    2. Main results due

      Jun 2027

    3. Finished

      Jun 2027

    Assembled by software from public sources.